                         SEQUENCE LISTING

<110>  Pereira, Heloise A
       Kasus-Jacobi, Anne
       Gina, Griffith L
 
<120>  PEPTIDE COMPOUNDS AND METHODS OF PRODUCTION AND USE THEREOF

<130>  5835.141wo

<150>  PCT/US2013/072884
<151>  2013-12-03

<150>  61/812,584
<151>  2013-04-16

<150>  61/813,527
<151>  2013-04-18

<160>  47    

<170>  PatentIn version 3.5

<210>  1
<211>  25
<212>  PRT
<213>  Homo sapiens

<400>  1

Asn Gln Gly Arg His Phe Ser Gly Gly Ala Leu Ile His Ala Arg Phe 
1               5                   10                  15      


Val Met Thr Ala Ala Ser Cys Phe Gln 
            20                  25  


<210>  2
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  derivative of a peptide of Homo sapiens CAP37 protein

<400>  2

Asn Gln Gly Arg His Phe Thr Gly Gly Ala Leu Ile His Ala Arg Phe 
1               5                   10                  15      


Val Met Thr Ala Ala Ser Cys Phe Gln 
            20                  25  


<210>  3
<211>  25
<212>  PRT
<213>  Artificial sequence

<220>
<223>  derivative of a peptide of Homo sapiens CAP37 protein

<400>  3

Asn Gln Gly Arg His Phe Met Gly Gly Ala Leu Ile His Ala Arg Phe 
1               5                   10                  15      


Val Met Thr Ala Ala Ser Cys Phe Gln 
            20                  25  


<210>  4
<211>  25
<212>  PRT
<213>  Homo sapiens

<400>  4

Asn Gln Gly Arg His Phe Cys Gly Gly Ala Leu Ile His Ala Arg Phe 
1               5                   10                  15      


Val Met Thr Ala Ala Ser Ser Phe Gln 
            20                  25  


<210>  5
<211>  25
<212>  PRT
<213>  Artificial sequence

<220>
<223>  derivative of a peptide of Homo sapiens CAP37 protein

<400>  5

Asn Gln Gly Arg His Phe Cys Gly Gly Ala Leu Ile His Ala Arg Phe 
1               5                   10                  15      


Val Met Thr Ala Ala Ser Thr Phe Gln 
            20                  25  


<210>  6
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  derivative of a peptide of Homo sapiens CAP37 protein

<400>  6

Asn Gln Gly Arg His Phe Cys Gly Gly Ala Leu Ile His Ala Arg Phe 
1               5                   10                  15      


Val Met Thr Ala Ala Ser Met Phe Gln 
            20                  25  


<210>  7
<211>  25
<212>  PRT
<213>  Homo sapiens

<400>  7

Asn Gln Gly Arg His Phe Cys Gly Gly Ala Leu Ile His Ala Arg Phe 
1               5                   10                  15      


Val Met Thr Ala Ala Ser Cys Phe Gln 
            20                  25  


<210>  8
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  derivative of a peptide of Homo sapiens CAP37 protein

<400>  8

Arg His Phe Ser Gly Gly Ala Leu Ile His Ala Arg Phe Val Met Thr 
1               5                   10                  15      


Ala Ala Ser Cys 
            20  


<210>  9
<211>  20
<212>  PRT
<213>  artificial sequence

<220>
<223>  derivative of a peptide of Homo sapiens CAP37 protein

<400>  9

Arg His Phe Thr Gly Gly Ala Leu Ile His Ala Arg Phe Val Met Thr 
1               5                   10                  15      


Ala Ala Ser Cys 
            20  


<210>  10
<211>  20
<212>  PRT
<213>  artificial sequence

<220>
<223>  derivative of a peptide of Homo sapiens CAP37 protein

<400>  10

Arg His Phe Met Gly Gly Ala Leu Ile His Ala Arg Phe Val Met Thr 
1               5                   10                  15      


Ala Ala Ser Cys 
            20  


<210>  11
<211>  20
<212>  PRT
<213>  artificial sequence

<220>
<223>  derivative of a peptide of Homo sapiens CAP37 protein

<400>  11

Arg His Phe Cys Gly Gly Ala Leu Ile His Ala Arg Phe Val Met Thr 
1               5                   10                  15      


Ala Ala Ser Ser 
            20  


<210>  12
<211>  20
<212>  PRT
<213>  artificial sequence

<220>
<223>  derivative of peptide from Homo sapiens CAP37 protein

<400>  12

Arg His Phe Cys Gly Gly Ala Leu Ile His Ala Arg Phe Val Met Thr 
1               5                   10                  15      


Ala Ala Ser Thr 
            20  


<210>  13
<211>  20
<212>  PRT
<213>  artificial sequence

<220>
<223>  derivative of peptide of Homo sapiens CAP37 protein

<400>  13

Arg His Phe Cys Gly Gly Ala Leu Ile His Ala Arg Phe Val Met Thr 
1               5                   10                  15      


Ala Ala Ser Met 
            20  


<210>  14
<211>  20
<212>  PRT
<213>  Homo sapiens

<400>  14

Arg His Phe Cys Gly Gly Ala Leu Ile His Ala Arg Phe Val Met Thr 
1               5                   10                  15      


Ala Ala Ser Cys 
            20  


<210>  15
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  four arginine residue sequence

<400>  15

Arg Arg Arg Arg 
1               


<210>  16
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  five arginine residue sequence

<400>  16

Arg Arg Arg Arg Arg 
1               5   


<210>  17
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  six arginine residue sequence

<400>  17

Arg Arg Arg Arg Arg Arg 
1               5       


<210>  18
<211>  30
<212>  PRT
<213>  artificial sequence

<220>
<223>  5-arginine peptide derivative of CAP37 peptide

<400>  18

Arg Arg Arg Arg Asn Gln Gly Arg His Phe Ser Gly Gly Ala Leu Ile 
1               5                   10                  15      


His Ala Arg Phe Val Met Thr Ala Ala Ser Cys Phe Gln Arg 
            20                  25                  30  


<210>  19
<211>  30
<212>  PRT
<213>  artificial sequence

<220>
<223>  five-arginine derivative of a CAP37 peptide

<400>  19

Arg Arg Arg Arg Asn Gln Gly Arg His Phe Cys Gly Gly Ala Leu Ile 
1               5                   10                  15      


His Ala Arg Phe Val Met Thr Ala Ala Ser Ser Phe Gln Arg 
            20                  25                  30  


<210>  20
<211>  30
<212>  PRT
<213>  artificial sequence

<220>
<223>  five arginine peptide derivative of CAP37 peptide

<400>  20

Arg Arg Arg Arg Asn Gln Gly Arg His Phe Cys Gly Gly Ala Leu Ile 
1               5                   10                  15      


His Ala Arg Phe Val Met Thr Ala Ala Ser Cys Phe Gln Arg 
            20                  25                  30  


<210>  21
<211>  30
<212>  PRT
<213>  artificial sequence

<220>
<223>  BCC02-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  21

Arg Arg Arg Arg Asn Gln Gly Arg His Phe Ser Gly Gly Ala Leu Ile 
1               5                   10                  15      


His Ala Arg Phe Val Met Thr Ala Ala Ser Cys Phe Gln Arg 
            20                  25                  30  


<210>  22
<211>  30
<212>  PRT
<213>  artificial sequence

<220>
<223>  BCC03-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  22

Arg Arg Arg Arg Asn Gln Gly Arg His Phe Cys Gly Gly Ala Leu Ile 
1               5                   10                  15      


His Ala Arg Phe Val Met Thr Ala Ala Ser Ser Phe Gln Arg 
            20                  25                  30  


<210>  23
<211>  30
<212>  PRT
<213>  artificial sequence

<220>
<223>  BCC01-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  23

Arg Arg Arg Arg Asn Gln Gly Arg His Phe Cys Gly Gly Ala Leu Ile 
1               5                   10                  15      


His Ala Arg Phe Val Met Thr Ala Ala Ser Cys Phe Gln Arg 
            20                  25                  30  


<210>  24
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  BCC03-MP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  24

Asn Gln Gly Arg His Phe Cys Gly Gly Ala Leu Ile His Ala Arg Phe 
1               5                   10                  15      


Val Met Thr Ala Ala Ser Ser Phe Gln 
            20                  25  


<210>  25
<211>  20
<212>  PRT
<213>  artificial sequence

<220>
<223>  consensus sequence for Pep of Formula (I)


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Phe, Tyr, Arg, Lys, or His

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Cys, Ser, Thr, or Met

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Gly or Ala

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Gly or Ala

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Ala, Leu, Ile, or Val

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Ala, Leu, Ile, or Val

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Ala, Leu, Ile, or Val

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Phe, Tyr, Arg, Lys, or His

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Ala, Leu, Ile, or Val

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Ser, Thr, or Met

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Ala, Leu, Ile, or Val

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Ala, Leu, Ile, or Val

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Ser, Thr, or Met

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Cys, Ser, Thr, or Met

<400>  25

Arg His Xaa Xaa Xaa Xaa Xaa Xaa Xaa His Xaa Arg Xaa Xaa Met Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa 
            20  


<210>  26
<211>  28
<212>  PRT
<213>  Homo sapiens

<400>  26

Leu Asp Arg Glu Ala Asn Leu Thr Ser Ser Val Thr Ile Leu Pro Leu 
1               5                   10                  15      


Pro Leu Gln Asn Ala Thr Val Glu Ala Gly Thr Arg 
            20                  25              


<210>  27
<211>  21
<212>  PRT
<213>  Homo sapiens

<400>  27

Thr Ser Ser Val Thr Ile Leu Pro Leu Pro Leu Gln Asn Ala Thr Val 
1               5                   10                  15      


Glu Ala Gly Thr Arg 
            20      


<210>  28
<211>  27
<212>  PRT
<213>  Homo sapiens

<400>  28

Gly Thr Arg Cys Gln Val Ala Gly Trp Gly Ser Gln Arg Ser Gly Gly 
1               5                   10                  15      


Arg Leu Ser Arg Phe Pro Arg Phe Val Asn Val 
            20                  25          


<210>  29
<211>  27
<212>  PRT
<213>  artificial sequence

<220>
<223>  derivative of peptide of Homo sapiens CAP37 protein

<400>  29

Gly Thr Arg Cys Gln Val Ala Gly Trp Gly Ser Gln His Ser Gly Gly 
1               5                   10                  15      


Arg Leu Ser Arg Phe Pro Arg Phe Val Asn Val 
            20                  25          


<210>  30
<211>  27
<212>  PRT
<213>  artificial sequence

<220>
<223>  derivative of peptide of Homo sapiens CAP37 protein

<400>  30

Gly Thr Arg Cys Gln Val Ala Gly Trp Gly Ser Trp Arg Ser Gly Gly 
1               5                   10                  15      


Arg Leu Ser Arg Phe Pro Arg Phe Val Asn Val 
            20                  25          


<210>  31
<211>  27
<212>  PRT
<213>  artificial sequence

<220>
<223>  derivative of peptide of CAP37 protein

<400>  31

Gly Thr Arg Cys Gln Val Ala Gly Trp Gly Ser Trp His Ser Gly Gly 
1               5                   10                  15      


Arg Leu Ser Arg Phe Pro Arg Phe Val Asn Val 
            20                  25          


<210>  32
<211>  32
<212>  PRT
<213>  artificial sequence

<220>
<223>  120-146QR-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  32

Arg Arg Arg Arg Gly Thr Arg Cys Gln Val Ala Gly Trp Gly Ser Gln 
1               5                   10                  15      


Arg Ser Gly Gly Arg Leu Ser Arg Phe Pro Arg Phe Val Asn Val Arg 
            20                  25                  30          


<210>  33
<211>  32
<212>  PRT
<213>  artificial sequence

<220>
<223>  120-146QH-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  33

Arg Arg Arg Arg Gly Thr Arg Cys Gln Val Ala Gly Trp Gly Ser Gln 
1               5                   10                  15      


His Ser Gly Gly Arg Leu Ser Arg Phe Pro Arg Phe Val Asn Val Arg 
            20                  25                  30          


<210>  34
<211>  32
<212>  PRT
<213>  artificial sequence

<220>
<223>  120-146WR-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  34

Arg Arg Arg Arg Gly Thr Arg Cys Gln Val Ala Gly Trp Gly Ser Trp 
1               5                   10                  15      


Arg Ser Gly Gly Arg Leu Ser Arg Phe Pro Arg Phe Val Asn Val Arg 
            20                  25                  30          


<210>  35
<211>  32
<212>  PRT
<213>  artificial sequence

<220>
<223>  120-146WH-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  35

Arg Arg Arg Arg Gly Thr Arg Cys Gln Val Ala Gly Trp Gly Ser Trp 
1               5                   10                  15      


His Ser Gly Gly Arg Leu Ser Arg Phe Pro Arg Phe Val Asn Val Arg 
            20                  25                  30          


<210>  36
<211>  30
<212>  PRT
<213>  artificial sequence

<220>
<223>  20-44thr26-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  36

Arg Arg Arg Arg Asn Gln Gly Arg His Phe Thr Gly Gly Ala Leu Ile 
1               5                   10                  15      


His Ala Arg Phe Val Met Thr Ala Ala Ser Cys Phe Gln Arg 
            20                  25                  30  


<210>  37
<211>  30
<212>  PRT
<213>  artificial sequence

<220>
<223>  20-44met26-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  37

Arg Arg Arg Arg Asn Gln Gly Arg His Phe Met Gly Gly Ala Leu Ile 
1               5                   10                  15      


His Ala Arg Phe Val Met Thr Ala Ala Ser Cys Phe Gln Arg 
            20                  25                  30  


<210>  38
<211>  30
<212>  PRT
<213>  artificial sequence

<220>
<223>  20-44thr42-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  38

Arg Arg Arg Arg Asn Gln Gly Arg His Phe Cys Gly Gly Ala Leu Ile 
1               5                   10                  15      


His Ala Arg Phe Val Met Thr Ala Ala Ser Thr Phe Gln Arg 
            20                  25                  30  


<210>  39
<211>  30
<212>  PRT
<213>  artificial sequence

<220>
<223>  20-44met42-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  39

Arg Arg Arg Arg Asn Gln Gly Arg His Phe Cys Gly Gly Ala Leu Ile 
1               5                   10                  15      


His Ala Arg Phe Val Met Thr Ala Ala Ser Met Phe Gln Arg 
            20                  25                  30  


<210>  40
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  23-42ser26-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  40

Arg Arg Arg Arg Arg His Phe Ser Gly Gly Ala Leu Ile His Ala Arg 
1               5                   10                  15      


Phe Val Met Thr Ala Ala Ser Cys Arg 
            20                  25  


<210>  41
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  23-42thr26-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  41

Arg Arg Arg Arg Arg His Phe Thr Gly Gly Ala Leu Ile His Ala Arg 
1               5                   10                  15      


Phe Val Met Thr Ala Ala Ser Cys Arg 
            20                  25  


<210>  42
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  23-42met26-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  42

Arg Arg Arg Arg Arg His Phe Met Gly Gly Ala Leu Ile His Ala Arg 
1               5                   10                  15      


Phe Val Met Thr Ala Ala Ser Cys Arg 
            20                  25  


<210>  43
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  23-42ser42-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  43

Arg Arg Arg Arg Arg His Phe Cys Gly Gly Ala Leu Ile His Ala Arg 
1               5                   10                  15      


Phe Val Met Thr Ala Ala Ser Ser Arg 
            20                  25  


<210>  44
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  23-42thr42-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  44

Arg Arg Arg Arg Arg His Phe Cys Gly Gly Ala Leu Ile His Ala Arg 
1               5                   10                  15      


Phe Val Met Thr Ala Ala Ser Thr Arg 
            20                  25  


<210>  45
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  23-42met42-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  45

Arg Arg Arg Arg Arg His Phe Cys Gly Gly Ala Leu Ile His Ala Arg 
1               5                   10                  15      


Phe Val Met Thr Ala Ala Ser Met Arg 
            20                  25  


<210>  46
<211>  33
<212>  PRT
<213>  artificial sequence

<220>
<223>  95-122-5RMP


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  (AEEP)-(AEEP) linked to amino terminal end of peptide backbone

<400>  46

Arg Arg Arg Arg Leu Asp Arg Glu Ala Asn Leu Thr Ser Ser Val Thr 
1               5                   10                  15      


Ile Leu Pro Leu Pro Leu Gln Asn Ala Thr Val Glu Ala Gly Thr Arg 
            20                  25                  30          


Arg 
    


<210>  47
<211>  20
<212>  PRT
<213>  artificial sequence

<220>
<223>  consensus sequence for Pep of Formula (I)


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Phe, Arg, Lys, or His

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Cys, Ser, Thr, or Met

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Gly or Ala

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Gly or Ala

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Ala, leu, Ile, or Val

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Ala, leu, Ile, or Val

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Ala, leu, Ile, or Val

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Phe, Arg, Lys, or His

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Ala, leu, Ile, or Val

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Ser, Thr, or Met

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Ala, leu, Ile, or Val

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Ala, leu, Ile, or Val

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Ser, Thr, or Met

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Cys, Ser, Thr, or Met

<400>  47

Arg His Xaa Xaa Xaa Xaa Xaa Xaa Xaa His Xaa Arg Xaa Xaa Met Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa 
            20  


